Some variants located in HSD17B13 and MTARC1 offer protective effects, reducing the risk of severe liver disease despite comorbidities such as obesity, and can mitigate the harmful effects of these risk alleles. Here, HSD17B13 is linked to obesity due to melanocortin 4 receptor deficiency.